Home>>Analytical Standards>>4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) (Synonyms: Flephedrone metabolite, 4FMC metabolite)

Catalog No.GC42396

4-Fluoromethcathinone (4-FMC) is a fluorinated cathinone derivative identified in several designer drugs that are marketed as plant feeders.

Products are for research use only. Not for human use. We do not sell to patients.

4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) Chemical Structure

Cas No.: 7799-72-6

Size Price Stock Qty
500μg
$128.00
In stock
1mg
$194.00
In stock
5mg
$899.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4-Fluoromethcathinone (4-FMC) is a fluorinated cathinone derivative identified in several designer drugs that are marketed as plant feeders. This metabolite of 4-FMC features conversion of the β-keto group to β-hydroxy and is an enantiomeric mixture of the R,S and S,R orientations at carbons one and two, as in ephedrine. The physiological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research purposes.

Reviews

Review for 4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.